ABSTRACT. We examined the prevalence of human papiIIomavirus (HPV) infection, and associated risk factors for infection with HPV types 6, 11, 16, 18,31,33, and 35, in 661 sexually active adolescent females attending family planning clinics. Fifteen percent were positive for HPV DNA by RNA-DNA dot-blot hybridization. More than 60% of the HPV-positive subjects harbored at least one of the following cancer-related HPV types: 16, 18,31, 33, or 35. Those with HPV had a mean range of four to 10 lifetime sexual partners compared with a mean range of one to three in those without HPV (p < 0.001). After the analysis was adjusted for number of lifetime sexual partners, no other risk factor was associated with HPV infection. We conclude that oncogenic-related HPV types are common sexually transmitted organisms found in our population. The strong relationship with number of sexual partners suggests that acquisition of HPV infection is predominantly influenced by sexual behavior. However, in our population, confounders such as oral contraceptive use, past history of Chlamydia trachomatis infection, or substance abuse were not found to be significant independent risk factors. (Pediatr Res 28: 507-513, 1990) have been performed in populations with both HPV infection and neoplasia (i.e. dysplasia clinic populations), it has been difficult to differentiate cofactors associated with neoplasia from those associated with HPV infection. Distinguishing between the risk factors for HPV infection and those associated with progression to CIN or cancer is critical in understanding the pathogenesis of the disease because the risk factors may not be the same. Studies that examine populations with relatively early HPV infection, defined by a short exposure time, may be best suited for distinguishing these risk factors. Adolescents may serve as such a population because the rate of abnormal cytology in teens is lower than that found in older adult women, and adolescents have not been sexually active as long as most adult women. Therefore, the average time course from infection and acquisition of the virus to the gynecology clinic visit is expected to be less for the adolescent than for the older woman.
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The purposes of our study were to determine the prevalence of HPV types 6, II, 16, 18, 31, 33 , and 35 among a sexually active adolescent female population and to identify factors associated with acquisition of these specific HPV types.
SUBJECTS AND METHODS
All sexually active females aged 13 to 19 y attending family planning clinics and having a pelvic examination for any reason on the day of the study were asked to participate. Sites consisted of an urban university-based adolescent gynecology clinic and two community-based family planning clinics, one urban and one surburban. Reasons for visits included family planning, STD complaints, pregnancy-related problems, and other gynecologic problems. Persons attending the family planning clinics were predominantly lower to middle class citizens. Most of those who attended these clinics were white (60%); the rest were equally distributed among blacks (IS %), Hispanics (10%), and other ethnic groups (IS %). Pregnant subjects were excluded from the study because pregnancy may independently alter the course or expression of HPV infection. Patients currently on antibiotics were also excluded because these drugs could alter results for STD. Informed consent was obtained as approved by the Committee on Human Research from all eligible subjects who attended the study after the nature of the procedures was explained to them. The refusal rate for entry into the study was 10%. Information on race/ethnicity and clinic site was collected for those who refused. No differences were found between those who refused and those who participated for either of the variables.
History and physical examination. Subjects were given a selfadministered questionnaire to complete before examination. The questionnaire included information on sexual behaviors, type of contraceptive used within the past 60 d (more than one type could be reported) and frequency of its use using a 5-point scale (never/rarely/sornetimes/usually/always), substance use and fre-507 Abbreviations HPV, human papilloma virus CIN, cervical intraepithelial neoplasia STD, sexually transmitted disease Despite the strong link between the development of cancer of the uterine cervix and infection with HPV (1-3), the exact role of HPV in the establishment of this cancer remains unknown. Several studies (4-11) have indicated that, in addition to HPV infection, cofactors are most likely required for cervical neoplasia to develop. These factors have included use of oral contraceptives, cigarette smoking, infection of the cervix with Chlamydia trachomatis or herpes simplex virus, and impaired immune response (4) (5) (6) (7) (8) (9) (10) (11) . Because most studies examining these factors 508 MOSCICKI £T AL. Southern blot hybridi zation. Southern blot analyses, the current gold standard for HPV DNA detection , were perform ed on 79 samples not includ ed in th is study to validate the use of the RNA-DNA hybridizati on to detect HPV DNA in our popu lation . Samples were rand omly chosen from the three clinic sites described above. The cervical samples were first processed by the above described method. A similar aliquot (250 IlL) of the remaining digest was removed for Southern blot analysis.
Southern blot hybrid ization techniques for identificati on of HPV DNA have been described in detail (13) . The 250}lL of the dot-blot digest was placed into 1.5-mL Eppendorf tubes and a phen ol/chloroform (3: I) extraction was performed. The DNA was then precipitated with 3 M NaOAc a nd isopropan ol and the pellet was suspended in Tris-EDTA and then digested with Pstl. After electrophoresis in a 1% agarose gel, the gel was depurinated in 0.25 N HCl, denatured in 0.5 N NaOH/1.5 M NaCI, and neut ralized in 0.5 M Tris pH 7.5/ 3 M NaCl. Th e DNA was transferred to a Hybond-N membrane using stand ard Southern assembly. The membranes were hybridized at high stringency (melting temperature -10°C) in 2 mL of2 x 10 6 dpm /ml.zprobe hybridization solution using a mixture of HPV 6, II , 16, 18, 31, 33, and 35. Aut orad iogram s were exposed I d and 2 wk at -70°C and were interpreted without knowledge of the RNA-DNA hybridization results. Onl y those specimens with a recognizable banding pattern were considered positive. Southern blot results were recorded as positive or negative (Fig. 2) . Ten pg of each of the following unrestricted HPV DN A were added to th e gel as hybridi zation controls: HPV 6, II , 16, 18, 31, 33 (5.8-kb and 1.79-kb fragments) , and 35 (3.7-kb and 4.0-kb fragment s) (Fig.  2) . Insufficient material was available for comparisons between Southern blot and the RNA-DNA hybridizations that used the three separate probe combination.
Samples for culture of C. trachomatis were placed into antibiotic-containing medium and refrigerated for 24 h. Ten samples were refrigerated for 72 h, which was considered still adequate quen cy, and STD history. Attempts to validate the self-reports on STD history were made by reviewing the medical record of tho se subjects who had attended the clinic previously. Socioeconomi c status was measured by eliciting mothe r's highest level of education. Frequency of substance use was categorized int o four response groups: never; used substance a few time s per year; used substance at least once a month but less than once a week; and used substance at least once a week.
Rout ine gynecologic examination included gross visual inspection of the anogenital area for lesions consistent with condyloma acuminatum. The following were rout inely obtained from each subject: exocervical and endocervical samples for Pap smear; exocervical and endocervical samples obtained on Dacron swabs for detection of HPV DNA ; endocervical samples for culture of C. trachomatis and Neisseria gonorrhoeae; and vaginal samples for determination of pH and microscopic examination. Tests for herpes simplex virus, ectoparasites, syphilis, and other STD were performed when clinically indi cated.
Microbiology. RNA-DNA hybridiz ation. We used a commercially available RNA-DNA dot-blot hybridization technique [ViraPap (12) , Bethesda Research Laboratories, Gaithersburg, MD] to identify HPV DNA. Procedure techniques for the HPV DNA detection kit were performed according to the manufacturer's recommendation ( 12) . Cervical swabs for HPV were imm ediately placed into I mL of the sample transport medium and refrigerated at 4°C for no longer than 2 wk and at -70°C if longer than 2 wk before processing. Samples were processed as follows: samples were thawed to room temperature and were incubated after the additi on of a bacterial protease . Th e swabs were then remo ved. The DNA was denatured by the additi on of alkali and bound by filtration to a nylon membrane. The membrane-bound DNA was then hybridized to a mixture of radiolabeled probes that were specific for HPV types 6, II , 16, 18, 31, 33, and 35. The probe mixture consisted of < 5 }lCi of 32P-lab eled RNA probes prepared by in vitro transcript ion of recombinant plasmid containing substantially the entire DNA sequences of the seven HPV types. After hybridization, the nylon membrane was treated with ribonucl ease to remove the unhybridized probe and washed under condition of high stringency (meltin g temp erature -IODC) with 100 mM PBS solution with 10 (Fig. I) . Signals weaker than the low control but stronger than the negative control were recorded as weakly positive. For filtration , a 25-well filter manifold (Bethesda Research Laboratories) was used that allowed for the processing of 22 samples and three controls per membrane.
All signals stronger than the negative control were prepared for typing. Unused portions of the samples positive for the HPV probe mixture were then studied (ViraType, Bethesda Research Laboratories) under similar cond itions to determine the HP V type more precisely. Sample s were filtered onto three separate membranes, and each membrane was then hybridized with one of three separate radioacti vely labeled probe mixture s: 1) types 6 and 11 ; 2 ) types 16 and 18; and 3) types 31,33, and 35. Each membrane had four controls, one for each typing group and one negative, to control for possible cross-hybridization reaction s. Samples using the seven-prob e mixtu re that had weakly positive dot-blot signals, yet had negative dot-blot signals using the three separate probes, were recorded as negative. Samples using the seven-probe mixture that had definitely positive signals, yet had negative dot-blot signals using the thr ee separate probes, were recorded as "type undetermined." This table separates weakly positive from definitely positive dot-blot interpretations. Excluding the weakly positive, the sensitivity and specificity of the dot blot were 90 and 98%, respectively. Th e overall sensitivity and specificity of the RNA-DNA hybridization, inclusive of the weakly positive samples, were 92 and 96%, respectively (Fishers exact test; p < 0 .00 I).
Population description. Six-hund red sixty-one eligible adolescent females were enrolled in the study. The mean age was 17. 1 y (SD 1.5). Racial distribut ion of the population was 52 % white, 20 % black, 13% Hispan ic, and 15% other or mixed. Fifty-three percent reported that their mothers had gradu ated high school were categorized by frequen cy report ed. This categorization reflected a more reasonable interpretation for the effect of the variable. Those who reported using the meth od "usually" or "always" were categorized as consistent users. The "sometime" users were initially analyzed separat ely but were found to have similar associations to the "never/rarely" group. Therefore, those who "never," "rarely," or only "sometimes" reported using the method were categorized as negative or nonu sers. Subjects' self-reports of a previous STD were considered to meet the criterion for a positive STD history. However, when the self-report cont radicted the medical records, the subject's selfreport was preem pted. These data are discussed in Results.
In the initial analyses, several variables were found to be significantly associated with HP V infection including number of lifetime sexual partn ers. Additional analyses were then performed to exami ne the relationship between num ber of sexual partn ers and other variables that were associated with HPV .
These analyses included x 2 and t tests. For those variables found to have a significant association with numb er of sexual partners, we re-examined their association with HPV infection by using a log linear analysis model [Logit (18) ] to adjust for number of lifetim e sexual partn ers. The model adjusts for number of lifetime sexual partners by applying a goodness offi t test [Likelihood Ratio
Significance is reported by the change in U (t1L 2 ) between two models. The models examin e the association between the specified variable and HPV infection independently of its association with number of lifetime sexual partners. A significant univariate association found with a nonsignificant multi variate association did not necessarily indicate that the variable was unrelated to HPV; rather, it implied that the association of the variable with HPV was not independent of its relationship to the number of lifetim e sexual part ners in the mod el.
The association between HPV infection including HPV groups and cytologic chan ges was assessed by x 2 tests. Because the nu mber of subjects with CIN (2) was too small for analysis, subjects with CIN, condyloma, or atypia were collapsed into one category (abnor mal) and compared with those subjects with norm al cytology using x 2 tests. Descript ive inform ation is reported on the distribution of HPV groups between those subjects with CIN, condyloma, atypia, and benign smears. t See text for definition.
for culture by the university-based laborat ory (4). All samples were then processed ont o McCoy cell monol ayers and incubated in cycloheximide-containing medium. Identification of positive cultures is described elsewhere in detail (4) . N. gonorrhoeae samples were placed into charcoal medium and cultured by routine methods (14) . Trichomonas vaginalis was diagnosed by detection on normal saline wet smears or by visualization on Pap smear. Bacterial vaginosis was diagnosed if three of the following criteria were found on examination of vaginal fluid: 1) pH greater than 5; 2) more than 20 % clue cells; 3) fishy odor, detected when pot assium hybroxide was added to vaginal samples; and 4) presence of a grey homogeneous discharge ( 15) .
Cytology. Slides for cytology were immediately fixed in alcohol and prepared by standard methods ( 16). Slides for cytology were then sent to their respective routine cytology laboratories; one was university based, the other was a local private laboratory. Cytology was routinely screened by a cytotechnician and verified by a pathol ogist.
Cytologic diagnoses were categorized as benign, atypical, suggestive of condyloma, or suggestive of CIN with or without koilocytosis. Th e term CIN is used for easier reference although it is under stood that cytology cannot determine the site of origin of neoplastic cells (e.g. cervical versus vaginal). Standard criteria were used to define CIN and condyloma (17) . "Atypical" was diagnosed when rare abnormal cells (neoplastic or koilocytes) were found or when some, but not all, of the features of CIN or cond yloma (koilocytosis) appeared on Pap smears.
Data analysis. Associations between the presence or absence of HPV cervical infection, as defined by DNA hybridization, and various relevant dichotomous variables were determined by the x 2 test or the Fisher exact test. For continuous variables, mean differences between those with and without HPV cervical infection were subm itted to two-tailed t tests. The level for statistical significance was set at 0.05. Because little information is available with regard to risk for HP V infection in a population with a low prevalence of neoplasia, this level of significance allowed small effects to be detected. Tests were performed between those subjects with and without any HP V type and also between subjects with specific HP V groups: HPV types 6 and II ; 16 and 18; and 31, 33, and 35. T hose that had undetermi ned HP V types using ViraType were analyzed as a separate group . Statistical values are given for significant associations only.
Th e reported frequency of both oral contraceptive use and condom use varied widely ranging from "rarely" used to "always" used. Th erefore, the oral contraceptive and condom use variables Table 2 . R eported sexual behavior" * Some subjects did not answer all the questions, thus the denominators vary.
t fJ < 0.001.
onl y and 47% reported th at their mothers had at least some college experie nce. Three q uarters of the subjects had been seen for family plann ing reaso ns; the rest had been seen for STDrelated complaints. The mean age of men arche was 12.5 y (SD 1.3). One-hundred two subje cts (15%) were positive for HPV DNA. Of tho se subjects positiv e for a single HPV DNA group, 24 were positive for HPV types 6 or II , 38 for types 16 or 18, and 16 for types 31, 33, or 35. Specimen s from nine subjects were positi ve for two or more HP V groups: six subj ects for types 16 or 18 and 3 I, 33, or 35, two for types 6 or I I and 16 or 18, and one for all three groups. The HP V type of 15 stro ngly positive dot-blot sam ples could not be determined adequately by the ViraType technique. T here were no significant differences between subjects with and without HPV or amo ng HPV type group for age, race, socioecon om ic status, reason for visit, or age of men arche.
Preval ence for HPV DNA , mother's level of educ ation, age, reason for visit, and race were found to be similar for the nonuniversity clinics (n = 608) and university-based clinic populations. Because pre valen ces of HPV were similar and de mographic characteristics did not differ between sites, the clinic sites were not separated for ana lysis.
Sexual behaviors. No differences were found between th ose
with and witho ut HP V for age of sexual debut (me an y = 15.2 (SD 1.7) or number of years sexually active (mean y = 2.0 (SD 1.7). However, subjects who had HPV cervical infection had more lifetim e sexual partners than th ose who did not (x 2 = 24.5; p < 0.00 I after Yat es corr ection) (Ta ble 2). In contrast, the groups did not differ in the number of sexua l partners with in the 60 d preceding the study . Eighty percent of subjects reported having either none or on e sexual partner in the past 60 d. Within the group of subjects with HPV cervical infections, the specific HPV DN A group ident ified was not associated with the number o f rece nt or past sexua l partners (da ta not shown).
Contraception m ethod.
Many of th e ado lescents report ed using more than one type of contraception in th e past 60 d. Fort y-four percent of subjects repo rted ha ving used oral contracepti ves sometime during the past 60 d. Condom s, diaphragms, non vagina l inte rcourse, (anal or oral sex) and foam were used by 52, 6, IS, and 3%, respectively. Forty-one percent reported having used nothing at least on ce in the past 60 d. No differences were found between the rep ort ed use of the se methods and presence or absen ce of HPV. To examine the effect of oral contraceptive use more carefully, we identified thos e who reported using oral contracepti ves consistently in the past 60 d and no other method . Of tho se who used only ora l contracepti ves and used them consistently, 12 of 49 (26 %) were positive for HPV ; of th ose who did not fall into this category (which included tho se reporting another method used either in combinatio n with oral contrace ptives or alone) 87 of 592 (15%) were positive for HP V (x 2 = 3.400; p = 0.03). Onl y 3% of subjects report ed consistent use of cond om s as their only method of birth control; no differen ce was found between th ose with and witho ut HPV. Seventeen percent of subjects report ed using both oral contracept ives and condoms at varying frequ encies. Consistent users of both were too small to analyze.
After adj usting for number oflifetime partners, consi stent oral co ntraceptive use was no longer significant ly associated with HPV+ HPV-HP V cervical infection (D.U = 1.67, dj( I); P = 0.8). No differences were found for HPV group for any of the methods described. STD history. Th ere was no differenc e between subjects with and without HPV cervical infection for any current STD infection (Table 3) Not une xpectedly, condyloma acumi natum was also more likely to have been recognized at some time among those with HPV than among tho se without ( x 2 = 18.83; P < 0.001). The specific HPV DNA group detected was not associated with any of th e tested STD . However, 58% of th ose with type 6 or II had a past or current history of condyloma acuminatum co mpared with 22 % of those with types 16,1 8,31 , 33, or 35 [the rest ( 13%) were untypeable] ( p = 0.00 1, dat a not sho wn). Adequate informati on on herpes sim plex viru s infections was not available for ana lysis because the virus was not cultured routinely. By histo ry and clin ical sympto ms, onl y three subjects had a past or curre nt history.
R eliability of S TD reporting. For the 293 subjects for whom two sour ces of dat a were available, there was a 93% agreement overall between th e positive and negative self-reports of a STD and medical records. However, many of the adol escents may ha ve sought care at other institutions; thus, the negati ve medical chart find ings in those with a positive reported history ma y not be reliable . More specifically, the medical records of 20 of 39 Substance use. Cigarette use was not associated with HPV infection of the cervix; 32 of 87 subjects with HPV (37%) report ed current cigarette use, com pared with 153 of 468 (33%) of th ose without HPV (p = 0.5). No differences occurred for hist ory of past cigarett e use, number of cigarettes smoked per day , and past months of cigarette use between those with and with out HPV (data not shown). In contrast, marijuan a was used more frequently among subjects with HPV than amo ng those witho ut (x 2 = 9.19; P = 0.05) (Ta ble 4). Subje cts with HPV app eared more likely to use oth er drugs (includi ng cocaine, amphetamines, and Quaaludes) as well (x 2 = 13.91; P = 0.008). After we adj usted for number of lifetim e sexua l partners, marijuana use or drug use was no longer significantly associated with HP V cervica l infection (boU = 5. ( 4) , p = 0.5 , respectively). HPV group was not associated with frequency of substa nce use.
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Cytology. Cytol ogic diagnoses were available for 6 16 subjects (96 HPV positive and 520 HPV negative subjects). Of the 96 subjects with HPV, 73 (76%) had ben ign Pap smears, four had sme ars suggestive of condyloma, one had a smear with low-grade CIN with koilocytosis, one had a smear with low-grade CIN Our study indicates that HPV is the most prevalent sexually tran smitted organism in our adolescent female popul ation, having been detected in 15% of subjects between the ages of 14 and 19 y. In addition, the predomi nant HP V types detected were the cancer-related types 16, 18, 31, 33, and 35. Previous studies that * Several subjects did not an swer these qu estion s, thus denom inat or s vary. without koilocytosis, and 17 had atypical Pap smears. In contrast, of those 520 without HPV, 498 (96%) had benign smears, three had smears suggestive of cond yloma , none had CIN, and 19 had atypicals (x 2 = 50.816; p < 0.00 I after Yates correction) . When we compared differences between normal and abnormal cytology, we found that 23 of 45 (5 1%) of our subjects who had an ab normal Pap smear were positive for HP V DNA compared with 73 of 57 1 (13%) of those subjects who had a normal Pap smear (x 2 = 47.62; p < 0.001). Th e following describes the distribu tion of HPV groups for those subjects positive for HP V between cytologic diagnoses. Of those who had benign smears (n = 73), 22% were positive for group 6/ 11,60% for group 16/1 8/ 3 1/33 /35 , and the rest were undetermi ned. Of those with cytologic changes suggestive of cond yloma (n = 4), 50% were positive for group 6/11 , and 50% for group 16/18 / 31/33/3 5. Of those with atypia (n = 17), 35% were positive for group 6/ 11, 65% for group 16/ 18/3 1/33/35, and the rest were undetermined. Of the two subjects with CIN, one was positive for group 16 have reported other sexually tran smitted organisms as the most commo n causes of genital infections amo ng adolescents did not ident ify HP V infections by the app ropriate laboratory methods (19, 20) .
Rosenfeld et at. (2 1) reported a higher rate (38%) of HP V infection among adolescent females. However, their study was performed in a population of predomin antly inn er-city youth, who had documented high rates of STD infections and unplanned pregnancies in the study. Also, their method of collection using cervical lavages was more likely to identify vaginal and vulvar disease than our use of cervical swabs. Lastly, their study em ployed the Southern blot hybridization techn ique, which when performed at low stringency can determine if DNA of any papilloma virus is present (22) .
Our study used a standardized dot-blot technique, with sensitivities and specificities equivalent to that of South ern blot hybridization for the HP V types being sought. Th is technique was perform ed und er conditions of high stringency, resulting in identificati on of the HPV DNA types specified by the probe mixture only (types 6, 11 , 16, 18, 31, 33, and 35) . Comparatively, under high stringent conditions, Rosenfeld's study showed a similar prevalence rate (12%) as ours for types 6, 11, 16, and 18. However, und er low stringent conditions with probes specifically for types 6, 11, 16, and 18, 67% of their positive HP V group had un characterized HPV types. Cont rary to other studies (1-3, 23, 24) , this suggests that non-6, II , 16, 18 HPV types were the predo minate types found in their population. Similar to our findings, Martinez et at. (25) reported that 13% of their innercity sexually active adolescent females were positive for HPV DNA using low-stringency Southern blot analysis and only 16% of the samples were considered uncharacterized. This finding compared with Rosenfeld's may reflect the recently report ed lack of stan dardiz ation and reproducibility associated with Southern blot analysis for HP V DNA detection (26) .
Prevalence rates reported in adult women are also difficult to com pare because methods of HP V DNA detection vary from study to study. Kiviat et at. (27) , using a combination of a dot blot and Southern hybridization to detect types 6, II, 16, 18, and 3 1, reported a slightly lower prevalence than in our population for HPV DNA in women attending either an ST D clinic (1 1%) or a college study health clinic (9%). de Villiers et at. (28) , using a filter in sill! hybridization technique, found that 10% of women aged less than 20 y and attending outp atient clinics in a German univer sity were positive for HPV DNA types 6, 11, 16, and 18. However, they also found that women older than 50 y had a prevalence rate ofless than 5%.
Th is information in regard to the higher prevalence of HP V in populations of adolescents than in older women suggests that adolescents may be at higher risk for HP V infection. It has been postulated that the biologic imma turity of the cervix associated with normal adolescent developm ent may leave the adolescent cervix vulnerable to STD infection including HP V (29, 30) . In a previous study, we noted that biologic imm aturity measured by Onc e/w k age of menarche was associated with CIN in adolescents (3 1). T he lack of the association between HP V infectio n and menarcheal age in th is study may reflect the importa nce of biologic immaturity in the role of neoplastic development rather tha n HP V infection inasmuch as the rate of neoplasia (0.3%) was extreme ly low in our group. Risk factors associated with cervical neoplasia have included mult iple sexual partners , use of oral contraceptives, C. trachomatis infection, menarcheal age, and cigarette smoki ng (4-6, 3 1-33). In our study, all of these cofactors except cigarette smo king and menarcheal age were associated with HPV infection using univa riate an alysis only. A history of mult iple sexual partners was stro ngly associated with HP V infection, as has been reported for other STD (32, 33) . T his most likely reflects multiple exposures to HP V-infected consorts. On the other hand , the nu mber of sexual part ners in the past 60 d did not differ between HP V-infected and nonin fected subjects, possibly due to th e relative insen sitivity of the dot blot for detecting low viral copy numbers, which may be present early in the course of transmission and infection.
It has been suggested that hor mon es play an important role in the course of HP V infection, perhaps by establishing an app ropriate cervical milieu or by enhancing viral replication (I , 5, 6, 34) . Others have ind icated that C. trachomatis infection may create a desirable milieu for HPV by disruption of the cervical barrier and repara tive stimu lation of cell division (2, 35) . Ou r univariate analysis originally suggested that a specific sequence of events may increase the risk for HPV infection because past history of C. trachomatis rather than current history alone was positively associated with detection of HPV DNA. Our ability to draw meanin g from history of past infection is limited in this study because of its dependence on subject reporting. However, both oral contrace ptive use and C. trachoma tis infection were no longer associated with HP V infection in the m ultivariate analysis, suggesting that these risk factors are not independent of sexual lifestyles.
Substance use has not previously been identified as a risk for CIN development. However, the literature lacks studies that have specifically examined this association. We hypothesized that significant substance use may be related to depression of the host immune response and may play an important role in infection and possibly neoplastic development (36, 37) . Our study found that frequent substance use was univariately associated with HPV infection ; however, it was no longer statistically significant after we adjusted for multiple partn ers.
Cigarette use has also been reported as a significant risk factor for CIN (38) . As with menarcheal age, the lack of a positive association between cigarette use and HP V infection in our popul ation underscores the need to differentiate between risk factors for HP V infection and those for CIN.
Th e lack of significant abn orm al pathology on Pap smears in our adolescent subjects reflects the validity of studying this population to identify specific risk factors for HP V infection before the onset of high-grade neoplastic lesions. However, it is well recognized that cytology remains an insensitive tool for diagnosing neoplasia (39) , a nd that a more sensitive test such as colposcopy and histology mu st be used to correctly different iate tho se women with and without neoplasia. Therefore, this study did not attempt to differentiate these groups for risk factors.
In summary , our study shows the cancer-related HPV types are common sexually transm itted path ogens among adolescents. The only risk factor identified for HP V infection was related to sexual behavior. Use of oral contraceptives, history of C. trachomati s infection, and frequent substance use may be related to the acq uisition of HP V; however, we were unable to demonstrate that these factors were indepe ndent from choice of sexual lifestyles. With the exception of smoking and late menarcheal age, this list of risk factors appears similar to those risk factors associated with CIN. Th is suggests that certain factors associated with CIN may in fact reflect their role in the establishment of HPV infection rathe r than a direct association with the development of neoplasia. Because the inte rrelationship between behaviors and infections is complex and neoplasia is a timedependent event, only longitudinal studies can distinguish these differences. In addition, standardization of tests for investigational use remains critical.
